Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Wachovia Keeps Market Perform on Visx


Wachovia keeps its market perform rating on Visx (EYE).

Analyst Theodore Huber says first-quarter earnings per share are above his 21 cents forecast and 20 cents consensus. He notes 20% volume growth, and a 34% custom mix was well ahead of his 11% and 32% estimates, respectively.

Huber raised the 70 cents 2004 earnings per share estimate to 80 cents. But he notes his higher growth estimates are largely offset by co-op marketing spending that he now is factoring into his model, driving a reduction in the $1.03 2005 earnings per share estimate to $1.01. He says with rival Alcon's astigmatism approval expected soon, and continued gains from Bausch & Lomb, he expects Visx's growth to decelerate in the coming quarters. Huber has a $24 to $26 valuation range.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus